VAERS reports by lot

GSK Varicella/Shingles lot G45LN: VAERS reports

53 VAERS reports list lot G45LN as a GSK Varicella/Shingles vaccine, received between 2018-11-12 and 2019-06-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
53
Reports
4%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction7134%
General / Systemic (non-local)4321%
Gastrointestinal199%
Neurological178%
Dermatological (non-injection-site)157%
Cardiac / Cardiovascular126%
Allergic / Anaphylactic94%
Musculoskeletal94%
Respiratory63%
Thrombotic / Hematological52%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Virginia5
New York5
Indiana4
Maine4
Illinois3
Alabama3
Pennsylvania3
North Carolina3
South Carolina2
Tennessee2
Ohio2
New Jersey2

Reports by month received

2018-1111
2018-1218
2019-012
2019-0211
2019-037
2019-041
2019-052
2019-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.